跳至主要内容
临床试验/JPRN-UMIN000041485
JPRN-UMIN000041485已完成未知

Efficacy trial of ingestion of plant derived ingredient. [g2020004(KO22)] - Efficacy of plant derived ingredient [g2019004]

Kao Corporation0 个研究点目标入组 16 人开始时间: 2020年8月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
16

研究概览

简要总结

A significant difference was observed in the primary outcome.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 60years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • (1) Diabetes mellitus (2) Taking medicine related diabetes mellitus (3) BMI>=30kg/m2 (4) Blood triglyceride>=150mg/dL (5) Taking antihypertensive (6) Having history or presence of cardiovascular disease or cerebrovascular disease (7) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (8) Having history of resection of gastrointestinal tract (9) Thyroid deficiency (10) Heavy alcohol drinker (over 30g per day) (11) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study or severe anemia (12) Having felt sick during blood collection (13) Food allergies for test foods or lactose intolerance (14) Tape allergy (15) Caffeine hypersensitivity (16) Planned to participate in other clinical study during current study (17) Shift worker (18) Planned to be examined by X-ray, CT, or MRI (19) Using an implantable medical device such as a pacemaker (20) Undergoing artificial dialysis (21) Within the last 2 weeks, having flu symptoms such as fever, cough, or sore throat, high fever, dyspnea, strong malaise, taste disorders, or olfactory disorders (22) Within the last 2 weeks, having family members or friends infected with COVID-19 or having close contact with infected person (23) Having overseas travel history within 1 month (24) Determined to be unqualified by the physician in charge or the responsible person of the study

研究者

相似试验